4 research outputs found
Emulating the Human Mind: A Neural-symbolic Link Prediction Model with Fast and Slow Reasoning and Filtered Rules
Link prediction is an important task in addressing the incompleteness problem
of knowledge graphs (KG). Previous link prediction models suffer from issues
related to either performance or explanatory capability. Furthermore, models
that are capable of generating explanations, often struggle with erroneous
paths or reasoning leading to the correct answer. To address these challenges,
we introduce a novel Neural-Symbolic model named FaSt-FLiP (stands for Fast and
Slow Thinking with Filtered rules for Link Prediction task), inspired by two
distinct aspects of human cognition: "commonsense reasoning" and "thinking,
fast and slow." Our objective is to combine a logical and neural model for
enhanced link prediction. To tackle the challenge of dealing with incorrect
paths or rules generated by the logical model, we propose a semi-supervised
method to convert rules into sentences. These sentences are then subjected to
assessment and removal of incorrect rules using an NLI (Natural Language
Inference) model. Our approach to combining logical and neural models involves
first obtaining answers from both the logical and neural models. These answers
are subsequently unified using an Inference Engine module, which has been
realized through both algorithmic implementation and a novel neural model
architecture. To validate the efficacy of our model, we conducted a series of
experiments. The results demonstrate the superior performance of our model in
both link prediction metrics and the generation of more reliable explanations
Clinical effects of topical antifungal therapy in chronic rhinosinusitis: a randomized, double-blind, placebo-controlled trial of intranasal fluconazole
Several studies have been in favor of fungi as a possible pathogenesis of chronic rhinosinusitis (CRS); however, to date, there is no scientific consensus about the use of antifungal agents in disease management. The aim of the present study was to investigate the efficacy of intranasal fluconazole in improving disease symptoms and objective outcomes of patients with CRS. A randomized, double-blind, placebo-controlled study was conducted on 54 patients who were diagnosed with CRS and had not been responsive to routine medical treatments. They were randomly assigned to receive either fluconazole nasal drop 0.2 % or placebo in addition to the standard regimen for a duration of 8 weeks. Patients’ outcomes were evaluated according to Sino-Nasal Outcome Test 20 (SNOT-20), endoscopic scores, and Computed Tomography (CT) scores. No statistically significant difference was found in SNOT-20 (p = 0.201), endoscopic (p = 0.283), and CT scores (p = 0.212) of the patients at baseline and after 8-week course of treatment between drug and placebo group. Similar to many studies, the use of topical antifungal treatment for patients with CRS was not shown to be significantly effective. However, further studies are needed to obtain high levels of consistent evidence in order to arrive at a decision whether antifungal therapy is effective in management of CRS or not
CLINICAL EFFECTS OF TOPICAL ANTIFUNGAL THERAPY IN CHRONIC RHINOSINUSITIS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF INTRANASAL FLUCONAZOLE
ABSTRACT Several studies have been in favor of fungi as a possible pathogenesis of chronic rhinosinusitis (CRS); however, to date, there is no scientific consensus about the use of antifungal agents in disease management. The aim of the present study was to investigate the efficacy of intranasal fluconazole in improving disease symptoms and objective outcomes of patients with CRS. A randomized, double-blind, placebo-controlled study was conducted on 54 patients who were diagnosed with CRS and had not been responsive to routine medical treatments. They were randomly assigned to receive either fluconazole nasal drop 0.2 % or placebo in addition to the standard regimen for a duration of 8 weeks. Patients' outcomes were evaluated according to Sino-Nasal Outcome Test 20 (SNOT-20), endoscopic scores, and Computed Tomography (CT) scores. No statistically significant difference was found in , endoscopic (p = 0.283), and CT scores (p = 0.212) of the patients at baseline and after 8-week course of treatment between drug and placebo group. Similar to many studies, the use of topical antifungal treatment for patients with CRS was not shown to be significantly effective. However, further studies are needed to obtain high levels of consistent evidence in order to arrive at a decision whether antifungal therapy is effective in management of CRS or not